- Home
- FWONK vs BNTX Comparison
FWONK vs BNTX Comparison
Compare FWONK & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FWONK | BNTX |
|---|---|---|
| Founded | 1950 | 2008 |
| Country | United States | Germany |
| Employees | 1674 | N/A |
| Industry | Broadcasting | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7B | 24.2B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | FWONK | BNTX |
|---|---|---|
| Price | $85.63 | $100.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | $110.88 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 1.6M | 781.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.56 | N/A |
| Revenue Next Year | $5.52 | $3.37 |
| P/E Ratio | $107.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $80.15 | $79.81 |
| 52 Week High | $109.36 | $124.00 |
Technical Indicators
Market Signals| Indicator | FWONK | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.19 | 52.71 |
| Support Level | $82.96 | $99.08 |
| Resistance Level | $90.12 | $113.05 |
| Average True Range (ATR) | 2.17 | 3.66 |
| MACD | -0.46 | 0.24 |
| Stochastic Oscillator | 15.16 | 41.11 |
Price Performance
Historical ComparisonAbout FWONK Liberty Media Corporation Series C Liberty Formula One
Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. It operates in two reportable segment Formula 1 and MotoGP. It generates majority of its revenue from the Formula 1 segment. The company derives its maximum revenue from United Kingdom.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.